Emma Holliday Obgyn

Specialized in gastrointestinal tract cancers, she says that the desire to be close to patients and their families and the possibility of having an impact concerning research in gastrointestinal cancer treatment motivated her choice in this field.

Emma Holliday High Yield Lectures

Emma Holliday High Yield is a reliable source of information structured by a series of 2 hours long videos that puts together all you need to know in order to become a good practitioner.

Who is Emma B. Holliday?

Emma Holliday, also known as Emma Holliday Ramahi, is a young assistant professor specialized in gastrointestinal radiation oncology at the MD Anderson Center at Texas University Hospital.

Brilliant, she will first have studied biochemistry and molecular biology at the University of Boston and then proceed to medicine studies at the University of Texas.

Specialized in gastrointestinal tract cancers, she says that the desire to be close to patients and their families and the possibility of having an impact concerning research in gastrointestinal cancer treatment motivated her choice in this field.

What is Emma Holliday High Yield?

If you haven’t heard about Emma Holliday before you must be wondering why an article about this specific doctor on a medical student counseling site.

You have to know that while she was in her 4th year (MS4), she put together a series of 2 hours long filmed courses associated with slides, principally intended for any student in his clinical year. She covered most of what you need to know to be a good clinician and smash your exams using question-answers slides dealing with pediatrics, surgery, internal medicine, and psychiatry.

Emma Holliday High Yield Pediatrics

Pediatrics is certainly one of the longest courses when it comes to reviewing. Using two hours of videos, Emma Holliday discusses the majority of pediatric issues in the following topics:

• APGAR scoring
• Neonatal screening
• Neonatal jaundice
• Respiratory + GI + GU disorders
• Genetic diseases and syndromes
• Genetic disease and syndromes
• Growth and development
• Heart + respiratory + renal + endocrine diseases
• Hemato Oncology
• Pathology of bones and joints
• Neurology

You can download the High Yield Pediatrics PDF course written by Emma Holliday by following this link.

Emma Holliday High Yield Surgery

High yield surgery is another two hours course that covers a large majority of surgical-related topics related to the Step2CK exam, including the following:

• Preoperatory evaluation
• Acid-base disorders
• Bruns
• Trauma
• Thoracic + Endocrine + GI disorders
• Murmurs
• Oncology
• Orthopedic
• Anesthesia

You can download the High Yield Surgery PDF course written by Emma Holliday by following this link.

Emma Holliday High Yield Internal Medicine

In this two hours long course, which focuses on Internal Medicine, Emma Holliday deals with:

• Cardiology
• Pneumology
• Gastroenterology
• Infectious Disease
• Nephrology
• Hemato Oncology
• Rheumatology
• Dermatology
• Endocrinology
• Neurology

You can download the High Yield Internal Medicine PDF course written by Emma Holliday by following this link.

Emma Holliday High Yield Psychiatry

Psychiatry was the last topic Emma Holliday touched on. In this last two hours of video, Emma Holliday will answer questions related to:

• Depressive + Eating + Sleeping + Anxiety + Attachment disorders
• Psychosis
• Schizophrenia
• Phobias + personality disorders
• Dementia + memory loss
• Seizures
• Addictions
• Intellectual disabilities

You can download the High Yield Psychiatry PDF course written by Emma Holliday by following this link.

Is Emma Holliday High Yield useful?

To get the most benefit from these videos, it would be wise to use them at the last moment when you’ll be studying. They should be used as fast revising material or to write some fast summaries.

To study Emma Holliday High Yield courses effectively, I would first suggest you to download the PDF slides to annotate any important information. This way, when the time of revision comes, you will not have to rewatch the videos, thus saving a tremendous amount of time.

You should know that during the presentation of her slide show Emma Holliday gives details and highlights important information and important pitfalls. Remember that it is always possible to increase the playback speed of videos.

Emma brings up several important details that she believes are frequently asked by the examiners to the student.

These slides will give you an overview of the most important subjects of your Clinical years. This is a simple and effective way to go over all the material in no time.

Here flashcards can be a fun and efficient way to learn different concepts quickly. You can find premade decks on Emma Holliday High Yield on different flashcard platforms such as Anki or Quizlet by following these links.

If you are not yet familiar with these study tools, note that they use different techniques like spaced repetition, gamification, and tests to help you learn information by hitting long-term memory.

If you haven’t made up your mind on the best flashcard study tool, I suggest reading the Quizlet vs Anki article, where I explained what are the Pros and the Cons of each.

Free Emma Holliday High Yield Flashcards

Final Words

These courses take into account general notions that all medical students crucially need to know. It is a quick, interesting, and interactive way to review all of the material essential to a good clinician. You won’t lose your time by studying these for sure!

Emma B. Holliday, M.D.

Dr. Holliday is an Associate Professor in the Gastrointestinal (GI) Radiation Oncology Section at MD Anderson.

The MD Anderson GI Radiation Oncology Section represents decades of GI cancer expertise by nine radiation oncology doctors, and a specialized team of GI radiotherapy physician assistants, nurses, physicists, therapists, and dosimetrists. We treat cancers of the stomach, liver, bile duct, pancreas, rectum, and anus. We offer every type of radiotherapy technology including intensity modulated radiation therapy (IMRT), stereotactic body radiation therapy (SBRT), and proton therapy, always selected and personalized for each patient. We are constantly working to improve radiotherapy for GI cancers, and offer many clinical trials designed to make radiotherapy more effective with fewer side effects.

Dr. Holliday treats all types of GI cancers. She is well-known for her research in advanced radiation technologies including proton therapy. She also has an interest in medical education and gender studies. She has published over 50 research and scientific articles, as well as several textbook chapters.

Meet Emma Holliday, M.D.

In the News

3 myths about anal cancer, debunked

Anal cancer vs. colorectal cancer: What’s the difference?

Liver cancer: What you should know

Primary Appointment

Associate Professor, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Degree-Granting Education

2011	University of Texas Health Science Center at San Antonio, San Antonio, TX, USA, MD, Internal Medicine
2006	Boston University, Boston, MA, USA, BA, Biochemistry and Molecular Biology, Honors Program

Postgraduate Training

2012-2016	Clinical Residency, Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
2011-2012	Clinical Internship, Internal Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, TX

2022	Delcos Teaching Award, MDACC Rad Onc Residency
2021	Educator of the Year, Association of Residents in Radiation Oncology (ARRO)
2015	RSNA Roentgen Resident Research Award, RSNA
2013	ASTRO Resident Poster Viewing Recognition Award – Clinical, ASTRO
2012	Outstanding Intern in Medical Student Education

Peer-Reviewed Articles

1. Lin YM, Fellman BM, Taiji R, Paolucci I, Silva JAM, Koay EJ, Avritscher R, Mahvash A, Holliday EB, Lee SS, Kaseb AO, Das P, Vauthey JN, Odisio BC . Salvage Locoregional Therapy Following Progression After Radiotherapy for Hepatocellular Carcinoma Is Associated with Improved Outcomes. J Gastrointest Surg 27(9):1867-1875, 2023. e-Pub 2023. PMID: 37268830.
2. Rooney MK, De B, Corrigan K, Smith GL, Taniguchi C, Minsky BD, Ludmir EB, Koay EJ, Das P, Koong AC, Peacock O, Chang G, You YN, Morris VK, Nogueras-González G, Holliday EB . Patient-reported Bowel Function and Bowel-related Quality of Life After Pelvic Radiation for Rectal Adenocarcinoma: The Impact of Radiation Fractionation and Surgical Resection. Clin Colorectal Cancer 22(2):211-221, 2023. e-Pub 2023. PMID: 36878805.
3. Holliday EB, Peddireddy A, Morris VK . Prognostic and Predictive Markers for Patients With Anal Cancer. J Natl Compr Canc Netw 21(6):678-684, 2023. PMID: 37308122.
4. Dodoo GN, De B, Lee SS, Abi Jaoude J, Vauthey JN, Tzeng CD, Tran Cao HS, Katlowitz KA, Mandel JJ, Beckham TH, Minsky BD, Smith GL, Holliday EB, Koong AC, Das P, Taniguchi CM, Javle M, Koay EJ, Ludmir EB . Brain Metastases from Biliary Tract Cancer: Case Series and Clinicogenomic Analysis. Oncologist 28(4):327-332, 2023. e-Pub 2023. PMID: 36715178.
5. Hernandez S, Das P, Holliday EB, Shen L, Lu W, Johnson B, Messick CA, Taniguchi CM, Skibber J, Ludmir EB, You YN, Smith GL, Bednarski B, Kostousov L, Koay EJ, Minsky BD, Tillman M, Portier S, Eng C, Koong AC, Chang GJ, Foo WC, Wang J, Soto LS, Morris VK . Differential Spatial Gene and Protein Expression Associated with Recurrence Following Chemoradiation for Localized Anal Squamous Cell Cancer. Cancers (Basel) 15(6), 2023. e-Pub 2023. PMID: 36980587.
6. Gunther JR, De La Cruz D, Boyce-Fappiano D, Ponnie AE, Smith L, Holliday EB, Bishop AJ, Choi SL, Koong AC, Das P, Pinnix CC . Implementation and Assessment of an Informal Virtual Elective for Medical Student Radiation Oncology Exploration During the COVID19 Pandemic: a Brief Report. J Cancer Educ 38(1):344-348, 2023. e-Pub 2022. PMID: 35013900.
7. Elnaggar JH, Huynh VO, Lin D, Hillman RT, Abana CO, El Alam MB, Tomasic KC, Karpinets TV, Kouzy R, Phan JL, Wargo J, Holliday EB, Das P, Mezzari MP, Ajami NJ, Lynn EJ, Minsky BD, Morris VK, Milbourne A, Messick CA, Klopp AH, Futreal PA, Taniguchi CM, Schmeler KM, Colbert LE . HPV-related anal cancer is associated with changes in the anorectal microbiome during cancer development. Front Immunol 14:1051431, 2023. e-Pub 2023. PMID: 37063829.
8. Yu C, Anakwenze CP, Zhao Y, Martin RM, Ludmir EB, S Niedzielski J, Qureshi A, Das P, Holliday EB, Raldow AC, Nguyen CM, Mumme RP, Netherton TJ, Rhee DJ, Gay SS, Yang J, Court LE, Cardenas CE . Multi-organ segmentation of abdominal structures from non-contrast and contrast enhanced CT images. Sci Rep 12(1):19093, 2022. e-Pub 2022. PMID: 36351987.
9. Lee A, Kuczmarska-Haas A, Dalwadi SM, Gillespie EF, Ludwig MS, Holliday EB, Chino F . Family Planning, Fertility, and Career Decisions Among Female Oncologists. JAMA Netw Open 5(10):e2237558, 2022. e-Pub 2022. PMID: 36315148.
10. De B, Corrigan KL, Rooney MK, Ludmir EB, Das P, Smith GL, Taniguchi CM, Minsky BD, Koay EJ, Koong A, Morris VK, Messick CA, You YN, Chang GJ, Westney OL, Nogueras Gonzalez GM, Holliday EB . Patient-reported bowel and urinary function in long-term survivors of squamous cell carcinoma of the anus treated with definitive intensity-modulated radiotherapy and concurrent chemotherapy. Int J Radiat Oncol Biol Phys 114(1):78-88, 2022. e-Pub 2022. PMID: 35589011.
11. Wang CX, Elganainy D, Zaid MM, Butner JD, Agrawal A, Nizzero S, Minsky BD, Holliday EB, Taniguchi CM, Smith GL, Koong AC, Herman JM, Das P, Maitra A, Wang H, Wolff RA, Katz MHG, Crane CH, Cristini V, Koay EJ . Mass transport model of radiation response: calibration and application to chemoradiation for pancreatic cancer. Int J Radiat Oncol Biol Phys 114(1):163-172, 2022. e-Pub 2022. PMID: 35643254.
12. Khan Z, Rooney MK, Das P, Ludmir EB, Koay EJ, Smith GL, Taniguchi C, Minsky BD, Koong AC, Sawakuchi G, Beddar S, Martin RM, Rodriguez-Bigas M, Peacock O, Chang G, Holliday EB . Intraoperative Radiation After Pelvic Short Course Radiation-Based Total Neoadjuvant Therapy for Patients With Rectal Adenocarcinoma at High Risk for Local Recurrence. Clin Colorectal Cancer 21(3):204-211, 2022. e-Pub 2022. PMID: 35125321.
13. Chapman BV, Rooney MK, Ludmir EB, De La Cruz D, Salcedo A, Pinnix CC, Das P, Jagsi R, Thomas CR, Holliday EB . Linguistic Biases in Letters of Recommendation for Radiation Oncology Residency Applicants from 2015 to 2019. J Cancer Educ 37(4):965-972, 2022. e-Pub 2020. PMID: 33111188.
14. Lin D, El Alam MB, Jaoude JA, Kouzy R, Phan JL, Elnaggar JH, Resendiz B, Medrano AYD, Lynn EJ, Nguyen ND, Noticewala SS, Mathew GG, Holliday EB, Minsky BD, Das P, Morris VK, Eng C, Mezzari MP, Petrosino JF, Ajami NJ, Klopp AH, Taniguchi CM, Colbert LE . Microbiome Dynamics During Chemoradiotherapy for Anal Cancer. Int J Radiat Oncol Biol Phys 113(5):974-984, 2022. e-Pub 2022. PMID: 35513187.
15. De B, Tran Cao HS, Vauthey JN, Manzar GS, Corrigan KL, Raghav KPS, Lee SS, Tzeng CD, Minsky BD, Smith GL, Holliday EB, Taniguchi CM, Koong AC, Das P, Javle M, Ludmir EB, Koay EJ . Ablative liver radiotherapy for unresected intrahepatic cholangiocarcinoma: Patterns of care and survival in the United States. Cancer 128(13):2529-2539, 2022. e-Pub 2022. PMID: 35417569.
16. Moningi S, Lei X, Fang P, Taniguchi CM, Holliday EB, Koay EJ, Koong AC, Ludmir EB, Minsky BD, Das P, Giordano SH, Smith GL . Contemporary use and outcomes of radiation and chemotherapy for unresectable pancreatic cancer. Clin Transl Radiat Oncol 35:9-16, 2022. e-Pub 2022. PMID: 35510142.
17. Corrigan KL, De B, Rooney MK, Ludmir EB, Das P, Smith GL, Taniguchi CM, Minsky BD, Koay EJ, Koong AC, Holliday EB . Patient-Reported Outcomes After Chemoradiation in Patients With Anal Cancer: A Qualitative Analysis. Adv Radiat Oncol 7(4):100986, 2022. e-Pub 2022. PMID: 35662810.
18. McClelland S, Huang CC, Griffith KA, Shan M, Holliday EB, Jagsi R, Zellars RC . Composition of the Current Academic Radiation Oncology Workforce in Comprehensive Cancer Centers. JCO Oncol Pract 18(5):OP2100609, 2022. e-Pub 2021. PMID: 34919411.
19. Manzar GS, De BS, Abana CO, Lee SS, Javle M, Kaseb AO, Vauthey JN, Tran Cao HS, Koong AC, Smith GL, Taniguchi CM, Holliday EB, Das P, Koay EJ, Ludmir EB . Outcomes and Toxicities of Modern Combined Modality Therapy with Atezolizumab Plus Bevacizumab and Radiation Therapy for Hepatocellular Carcinoma. Cancers (Basel) 14(8), 2022. e-Pub 2022. PMID: 35454808.
20. Taku N, Yi-Qian YN, Chang GJ, Ludmir EB, Raghav KPS, Rodriguez-Bigas MA, Holliday EB, Smith GL, Minsky BD, Overman MJ, Messick C, Boyce-Fappiano D, Koong AC, Skibber JM, Koay EJ, Dasari A, Taniguchi CM, Bednarski BK, Morris VK, Kopetz S, Das P . Benchmarking Outcomes for Definitive Treatment of Young-Onset, Locally Advanced Rectal Cancer. Clin Colorectal Cancer 21(1):e28-e37, 2022. e-Pub 2021. PMID: 34794903.
21. Rooney MK, Nesbit EG, Holliday EB, Jagsi R, Fuller CD, Ludmir EB, Sachdev S . Trends in Publication Speed of Radiation Oncology Research from 2010 to 2019. Adv Radiat Oncol 7(2):100863, 2022. e-Pub 2021. PMID: 35036635.
22. Bagley AF, Ludmir EB, Maitra A, Minsky BD, Li Smith G, Das P, Koong AC, Holliday EB, Taniguchi CM, Katz MHG, Tamm EP, Wolff RA, Overman MJ, Patel S, Kim MP, Tzeng CD, Ikoma N, Bhutani MS, Koay EJ . NBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experience. Clin Transl Radiat Oncol 33:66-69, 2022. e-Pub 2022. PMID: 35097226.
23. Colbert LE, El MB, Lynn EJ, Bronk J, Karpinets TV, Wu X, Chapman BV, Sims TT, Lin D, Kouzy R, Sammouri J, Biegert G, Delgado Medrano AY, Olvera A, Sastry KJ, Eifel PJ, Jhingran A, Lin L, Ramondetta LM, Futreal AP, Jazaeri AA, Schmeler KM, Yue J, Mitra A, Yoshida-Court K, Wargo JA, Solley TN, Hegde V, Nookala SS, Yanamandra AV, Dorta-Estremera S, Mathew G, Kavukuntla R, Papso C, Ahmed-Kaddar M, Kim M, Zhang J, Reuben A, Holliday EB, Minsky BD, Koong AC, Koay EJ, Das P, Taniguchi CM, Klopp A . Expansion of Candidate HPV-Specific T Cells in the Tumor Microenvironment during Chemoradiotherapy Is Prognostic in HPV16+ Cancers. Cancer Immunol Res 10(2):259-271, 2022. e-Pub 2022. PMID: 35045973.
24. Taparra K, Ebner DK, Cruz D, Holliday EB . The Impact of COVID-19 on Radiation Oncology Residency Applicant Away Rotations, Interviews, and Rank Lists: A Comparison Between the 2020 Match and 2021 Match. Adv Radiat Oncol 7(1):100842, 2022. e-Pub 2021. PMID: 34729444.
25. Corrigan KL, Rooney MK, De B, Ludmir ED, Das P, Smith GL, Taniguchi C, Minsky BD, Koay EJ, Koong A, Morris VK, Messick CA, Nogueras-Gonzalez G, Holliday EB . Patient-reported sexual function in long-term survivors of anal cancer treated with definitive intensity-modulated radiotherapy and concurrent chemotherapy. Pract Radiat Oncol 12(5):e397-e405, 2022. e-Pub 2022. PMID: 35643295.
26. De B, Abu-Gheida I, Patel A, Ng SSW, Zaid M, Thunshelle CP, Elganainy D, Corrigan KL, Rooney MK, Javle M, Raghav K, Lee SS, Vauthey JN, Tzeng CD, Tran Cao HS, Ludmir EB, Minsky BD, Smith GL, Holliday EB, Taniguchi CM, Koong AC, Das P, Koay EJ . Benchmarking Outcomes after Ablative Radiotherapy for Molecularly Characterized Intrahepatic Cholangiocarcinoma. J Pers Med 11(12), 2021. e-Pub 2021. PMID: 34945742.
27. Christopherson KM, Das P, Berlind C, Lindsay WD, Ahern C, Smith BD, Subbiah IM, Koay EJ, Koong AC, Holliday EB, Ludmir EB, Minsky BD, Taniguchi CM, Smith GL . A Machine Learning Model Approach to Risk-Stratify Gastrointestinal (GI) Cancer Patients for Hospitalization and Mortality Outcomes. Int J Radiat Oncol Biol Phys 111(1):135-142, 2021. e-Pub 2021. PMID: 33933480.
28. Odei B, Kahn J, Holliday EB, Diaz DA, Bello-Pardo E, Odei J, Bae J, Arnett A, Raval R, Mitchell D . Where Are the Women in Radiation Oncology? A Cross-Sectional Multi-Specialty Comparative Analysis. Adv Radiat Oncol 6(5):100735, 2021. e-Pub 2021. PMID: 34278054.
29. Taparra K, Ebner DK, De La Cruz D, Holliday EB . Away Rotations, Interviews, and Rank Lists: Radiation Oncology Residency Applicant Perspectives on the 2020 Match Process. Adv Radiat Oncol 6(4):100696, 2021. e-Pub 2021. PMID: 34113741.
30. Marsiglio JA, Rosenberg DM, Rooney MK, Goodman CR, Gillespie EF, Hirsch AE, Holliday EB, Kimple RJ, Thomas CR, Golden DW . Mentorship Initiatives in Radiation Oncology: A Scoping Review of the Literature. Int J Radiat Oncol Biol Phys 110(2):292-302, 2021. e-Pub 2021. PMID: 33412265.
31. Thaker NG, Boyce-Fappiano D, Ning MS, Pasalic D, Guzman A, Smith G, Holliday EB, Incalcaterra J, Garden AS, Shaitelman SF, Gunn GB, Fuller CD, Blanchard P, Feeley TW, Kaplan RS, Frank SJ . Activity-Based Costing of Intensity-Modulated Proton versus Photon Therapy for Oropharyngeal Cancer. Int J Part Ther 8(1):374-382, 2021. e-Pub 2021. PMID: 34285963.
32. Ha GL, Lehrer EJ, Wang M, Holliday E, Jagsi R, Zaorsky NG . Sex Differences in Academic Productivity Across Academic Ranks and Specialties in Academic Medicine: A Systematic Review and Meta-analysis. JAMA Netw Open 4(6):e2112404, 2021. e-Pub 2021. PMID: 34185071.
33. Wallington DG, Holliday EB . Preparing patients for sexual dysfunction after radiation for anorectal cancers: a systematic review. Pract Radiat Oncol 11(3):193-201, 2021. e-Pub 2020. PMID: 32777386.
34. Hester R, Advani S, Rashid A, Holliday E, Messick C, Das P, You YN, Taniguchi C, Koay EJ, Bednarski B, Rodriguez-Bigas M, Skibber J, Wolff R, Chang GJ, Minsky BD, Foo WC, Rothschild N, Morris VK, Eng C . CEA as a blood-based biomarker in anal cancer. Oncotarget 12(11):1037-1045, 2021. e-Pub 2021. PMID: 34084278.
35. Moningi S, Abi Jaoude J, Kouzy R, Lin D, Nguyen ND, Garcia Garcia CJ, Phan JL, Avila S, Smani D, Cazacu IM, Singh BS, Smith GL, Holliday EB, Koay EJ, Das P, Bhutani MS, Herman JM, Minsky BD, Koong AC, Taniguchi CM . Impact of Fiducial Marker Placement Before Stereotactic Body Radiation Therapy on Clinical Outcomes in Patients With Pancreatic Cancer. Adv Radiat Oncol 6(2):100621, 2021. e-Pub 2020. PMID: 33912734.
36. Augustyn A, Reed VI, Ahmad N, Bhutani MS, Bloom ES, Bowers JR, Chronowski GM, Das P, Holliday EB, Delclos ME, Huey RW, Koay EJ, Lee SS, Nelson CL, Taniguchi CM, Koong AC, Chun SG . Implementation of a stereotactic body radiotherapy program for unresectable pancreatic cancer in an integrated community academic radiation oncology satellite network. Clin Transl Radiat Oncol 27:147-151, 2021. e-Pub 2021. PMID: 33665384.
37. Odei B, Holliday EB, Jagsi R, Chino F, Schulmire C, Kudrimoti M, Chen AM, Raval R, Fabian D . Recruitment Challenges and Opportunities for Radiation Oncology Residency Programs during the 2020-2021 Virtual Residency Match. Int J Radiat Oncol Biol Phys 109(2):637-638, 2021. e-Pub 2020. PMID: 32798607.
38. Odei B, Das P, Pinnix C, Raval R, Holliday EB . Potential Implications of the New USMLE Step 1 Pass/Fail Format for Diversity Within Radiation Oncology. Adv Radiat Oncol 6(1):100524, 2021. e-Pub 2020. PMID: 33490722.
39. De B, Ng SP, Liu AY, Avila S, Tao R, Holliday EB, Brownlee Z, Kaseb A, Lee S, Raghav K, Vauthey JN, Minsky BD, Herman JM, Das P, Smith GL, Taniguchi CM, Krishnan S, Crane CH, Grassberger C, Hong TS, Lin SH, Koong AC, Mohan R, Koay EJ . Radiation-Associated Lymphopenia and Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with Radiotherapy. J Hepatocell Carcinoma 8:57-69, 2021. e-Pub 2021. PMID: 33688489.
40. Kouzy R, Abi Jaoude J, Lin D, El Alam MB, Minsky BD, Koay EJ, Das P, Holliday EB, Klopp AH, Colbert LE, Taniguchi CM . Patient-Reported GI Outcomes in Patients With Anal Cancer Receiving Modern Chemoradiation. JCO Oncol Pract 16(12):OP2000122, 2020. e-Pub 2020. PMID: 32609585.
41. Peters GW, Kuczmarska-Haas A, Holliday EB, Puckett L . Lactation challenges of resident physicians- results of a national survey. BMC Pregnancy Childbirth 20(1):762, 2020. e-Pub 2020. PMID: 33297993.
42. Peacock O, Limvorapitak T, Hu CY, Bednarski BK, Tillman MM, Kaur H, Taggart MW, Dasari A, Holliday EB, You YN, Chang GJ . Robotic rectal cancer surgery: comparative study of the impact of obesity on early outcomes. Br J Surg 107(12):1552-1557, 2020. e-Pub 2020. PMID: 32996597.
43. Noticewala SS, Ludmir EB, Eng C, Holliday EB, Minsky BD, Morris VK, Das P . Anal cancer treatment regimen considerations for the COVID-19 era: In regard to Tchelebi et al. Radiother Oncol 151:56-57, 2020. e-Pub 2020. PMID: 32710989.
44. Peacock O, Limvorapitak T, Bednarski BK, Kaur H, Taggart MW, Dasari A, Holliday EB, Minsky BD, You YN, Chang GJ . Robotic lateral pelvic lymph node dissection after chemoradiation for rectal cancer: a Western perspective. Colorectal Dis. e-Pub 2020. PMID: 32892473.
45. Somerson JS, Patton A, Ahmed AA, Ramey S, Holliday EB . Burnout Among United States Orthopaedic Surgery Residents. J Surg Educ 77(4):961-968, 2020. e-Pub 2020. PMID: 32171748.
46. Avila S, Chang GJ, Dasari NA, Smani DA, Das P, Herman JM, Koay E, Koong A, Krishnan S, Minsky BD, Smith GL, Taniguchi C, Taggart MW, Kaur H, Holliday EB . Pathologic Response and Postoperative Complications After Short-course Radiation Therapy and Chemotherapy for Patients With Rectal Adenocarcinoma. Clin Colorectal Cancer 19(2):116-122, 2020. e-Pub 2020. PMID: 32173279.
47. Moningi S, Ajani JA, Badgwell BD, Murphy MB, Ikoma N, Mansfield PF, Ho JC, Suh Y, Crane C, Herman JM, Holliday EB, Koay E, Koong AC, Krishnan S, Minsky B, Smith G, Taniguchi C, Das P . IMRT Reduces Acute Toxicity in Patients Treated With Preoperative Chemoradiation for Gastric Cancer. Adv Radiat Oncol 5(3):369-376, 2020. e-Pub 2019. PMID: 32529130.
48. Chang GJ, Holliday EB, Malakorn S . The Authors Reply. Dis Colon Rectum 63(4):e43, 2020. PMID: 32132468.
49. Ludmir EB, Fuller CD, Moningi S, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Verma V, Smith BD, Smith GL, VanderWalde NA, Holliday EB, Guadagnolo BA, Stinchcombe TE, Jagsi R, Gomez DR, Minsky BD, Rödel C, Fokas E . Sex-Based Disparities Among Cancer Clinical Trial Participants. J Natl Cancer Inst 112(2):211-213, 2020. e-Pub 2019. PMID: 31350545.
50. Dalwadi SM, Herman JM, Das P, Holliday EB . Novel Radiotherapy Technologies in the Treatment of Gastrointestinal Malignancies. Hematol Oncol Clin North Am 34(1):29-43, 2020. e-Pub 2019. PMID: 31739949.
51. Linscheid LJ, Holliday EB, Ahmed A, Somerson JS, Hanson S, Jagsi R, Deville C . Women in academic surgery over the last four decades. PLoS One 15(12):e0243308, 2020. e-Pub 2020. PMID: 33326486.
52. Moningi S, Ludmir EB, Polamraju P, Williamson T, Melkun MM, Herman JD, Krishnan S, Koay EJ, Koong AC, Minsky BD, Smith GL, Taniguchi C, Das P, Holliday EB . Definitive hyperfractionated, accelerated proton reirradiation for patients with pelvic malignancies. Clin Transl Radiat Oncol 19:59-65, 2019. e-Pub 2019. PMID: 31517071.
53. Malakorn S, Yang Y, Bednarski BK, Kaur H, You YN, Holliday EB, Dasari A, Skibber JM, Rodriguez-Bigas MA, Chang GJ . Who Should Get Lateral Pelvic Lymph Node Dissection After Neoadjuvant Chemoradiation?. Dis Colon Rectum 62(10):1158-1166, 2019. PMID: 31490825.
54. Beeler WH, Griffith KA, Jones RD, Chapman CH, Holliday EB, Lalani N, Wilson E, Bonner JA, Formenti SC, Hahn SM, Kalnicki S, Liu FF, Movsas B, Thomas CR, Jagsi R . Gender, Professional Experiences, and Personal Characteristics of Academic Radiation Oncology Chairs: Data to Inform the Pipeline for the 21st Century. Int J Radiat Oncol Biol Phys 104(5):979-986, 2019. e-Pub 2019. PMID: 30684662.
55. Ludmir EB, Mainwaring W, Miller AB, Lin TA, Jethanandani A, Espinoza AF, Holliday EB . Women’s Representation Among Lead Investigators of Clinical Trials in Oncology. JAMA Oncol. e-Pub 2019. PMID: 31393530.
56. Yeboa DN, Liao Z, Court L, Holliday EB, Spelman A, Herman J . Protocol-in-a-Day Workshop: A Lean Approach to Clinical Trial Development and Focus on Junior Faculty Development. Adv Radiat Oncol 4(3):439-442, 2019. e-Pub 2019. PMID: 31360796.
57. Chadha AS, Gunther JR, Hsieh CE, Aliru M, Mahadevan LS, Venkatesulu BP, Crane CH, Das P, Herman JM, Koay EJ, Taniguchi C, Holliday EB, Minsky BD, Suh Y, Park P, Sawakuchi G, Beddar S, Odisio BC, Gupta S, Loyer E, Kaur H, Raghav K, Javle MM, Kaseb AO, Krishnan S . Proton beam therapy outcomes for localized unresectable hepatocellular carcinoma. Radiother Oncol 133:54-61, 2019. e-Pub 2019. PMID: 30935582.
58. Zaorsky NG, Ahmed AA, Zhu J, Yoo SK, Fuller CD, Thomas CR, Choi M, Holliday EB . Industry Funding Is Correlated With Publication Productivity of US Academic Radiation Oncologists. J Am Coll Radiol 16(2):244-251, 2019. e-Pub 2018. PMID: 30219342.
59. Elhalawani H, Elgohari B, Lin TA, Mohamed ASR, Fitzgerald TJ, Laurie F, Ulin K, Kalpathy-Cramer J, Guerrero T, Holliday EB, Russo G, Patel A, Jones W, Walker GV, Awan M, Choi M, Dagan R, Mahmoud O, Shapiro A, Kong FS, Gomez D, Zeng J, Decker R, Spoelstra FOB, Gaspar LE, Kachnic LA, Thomas CR, Okunieff P, Fuller CD . An in-silico quality assurance study of contouring target volumes in thoracic tumors within a cooperative group setting. Clin Transl Radiat Oncol 15:83-92, 2019. e-Pub 2019. PMID: 30775563.
60. Moreno AC, Frank SJ, Garden AS, Rosenthal DI, Fuller CD, Gunn GB, Reddy JP, Morrison WH, Williamson TD, Holliday EB, Phan J, Blanchard P . Intensity modulated proton therapy (IMPT) – The future of IMRT for head and neck cancer. Oral Oncol 88:66-74, 2019. e-Pub 2018. PMID: 30616799.
61. Goldenberg BA, Holliday EB, Helewa RM, Singh H . Rectal Cancer in 2018: A Primer for the Gastroenterologist. Am J Gastroenterol 113(12):1763-1771, 2018. e-Pub 2018. PMID: 30008472.
62. Elganainy D, Holliday EB, Taniguchi CM, Smith GL, Shroff R, Javle M, Raghav K, Kaseb A, Aloia TA, Vauthey JN, Tzeng CD, Herman JM, Koong AC, Krishnan SX, Minsky BD, Crane CH, Das P, Koay EJ . Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinoma. Cancer Med 7(10):4880-4892, 2018. e-Pub 2018. PMID: 30152073.
63. Holliday EB, Siker M, Chapman CH, Jagsi R, Bitterman DS, Ahmed AA, Winkfield K, Kelly M, Tarbell NJ, Deville C . Achieving gender equity in the radiation oncology physician workforce. Adv Radiat Oncol 3(4):478-483, 2018. e-Pub 2018. PMID: 30370345.
64. Abdel-Rahman O, Elhalawani HM, Allen PK, Holliday EB . Utilization of short-course radiation therapy for patients with nonmetastatic rectal adenocarcinoma in the United States. Adv Radiat Oncol 3(4):611-620, 2018. e-Pub 2018. PMID: 30370362.
65. Colbert LE, Rebueno N, Moningi S, Beddar S, Sawakuchi GO, Herman JM, Koong AC, Das P, Holliday EB, Koay EJ, Taniguchi CM . Dose escalation for locally advanced pancreatic cancer: How high can we go?. Adv Radiat Oncol 3(4):693-700, 2018. e-Pub 2018. PMID: 30370371.
66. Grant SR, Smith BD, Likhacheva AO, Shirvani SM, Rosen DB, Guadagnolo BA, Shumway DA, Holliday EB, Chamberlain D, Walker GV . Provider variability in intensity modulated radiation therapy utilization among Medicare beneficiaries in the United States. Pract Radiat Oncol 8(5):e329-e336, 2018. e-Pub 2018. PMID: 29861349.
67. Holliday EB, Lester SC, Harmsen WS, Eng C, Haddock MG, Krishnan S, Das P, Hallemeier CL . Extended-Field Chemoradiation Therapy for Definitive Treatment of Anal Canal Squamous Cell Carcinoma Involving the Para-Aortic Lymph Nodes. Int J Radiat Oncol Biol Phys 102(1):102-108, 2018. e-Pub 2018. PMID: 29907489.
68. Ahmed AA, Yoo SK, Mehta S, Holliday EB, Deville C, Vapiwala N, Wilson LD, Jagsi R, Prasad V, Thomas CR . Meaningful and Accurate Disclosure of Conflict of Interest at the ASTRO National Meeting: A Need for Reassessment of Current Policies. J Oncol Pract:JOP1800121. e-Pub 2018. PMID: 30260714.
69. Holliday EB, Allen PK, Elhalawani H, Abdel-Rahman O . Outcomes of patients in the national cancer database treated non-surgically for localized rectal cancer. J Gastrointest Oncol 9(4):589-600, 2018. PMID: 30151255.
70. Hunt A, Das P, Minsky BD, Koay EJ, Krishnan S, Herman JM, Taniguchi C, Koong A, Smith GL, Holliday EB . Hyperfractionated abdominal reirradiation for gastrointestinal malignancies. Radiat Oncol 13(1):143, 2018. e-Pub 2018. PMID: 30086784.
71. Ahmed AA, Ramey SJ, Dean MK, Yoo SK, Holliday EB, Deville C, Takita C, Vapiwala N, Wilson LD, Jagsi R, Thomas CR, Yechieli R . Resident satisfaction with radiation oncology training. Adv Radiat Oncol 3(3):234-239, 2018. e-Pub 2018. PMID: 30197935.
72. Jones RD, Chapman CH,Holliday EB, Lalani N, Wilson E, Bonner JA, Movsas B, Kalnicki S, Formenti SC, Thomas CR, Hahn SM, Liu FF, Jagsi R, Society of Chairs of Academic Radiation Oncology Programs (SCAROP) . Qualitative Assessment of Academic Radiation Oncology Department Chairs’ Insights on Diversity, Equity, and Inclusion: Progress, Challenges, and Future Aspirations. Int J Radiat Oncol Biol Phys 101(1):30-45, 2018. e-Pub 2018. PMID: 29477292.
73. Amer AM, Zaid M, Chaudhury B, Elganainy D, Lee Y, Wilke CT, Cloyd J, Wang H, Maitra A, Wolff RA, Varadhachary G, Overman MJ, Lee JE, Fleming JB, Tzeng CW, Katz MH, Holliday EB, Krishnan S, Minsky BD, Herman JM, Taniguchi CM, Das P, Crane CH, Le O, Bhosale P, Tamm EP, Koay EJ . Imaging-based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography scans indicate response to cytotoxic therapy. Cancer 124(8):1701-1709, 2018. e-Pub 2018. PMID: 29370450.
74. Holliday EB, Allen PK, Elhalawani H, Abdel-Rahman O . Treatment at a high-volume centre is associated with improved survival among patients with non-metastatic hepatocellular carcinoma. Liver Int 38(4):665-675, 2018. e-Pub 2017. PMID: 28853231.
75. Rock CB, Prabhu AV, Fuller CD, Thomas CR, Holliday EB . Evaluation of the Relative Citation Ratio, a New National Institutes of Health-Supported Bibliometric Measure of Research Productivity, among Academic Radiation Oncologists. J Am Coll Radiol 15(3 Pt A):469-474, 2018. e-Pub 2018. PMID: 29301726.
76. Holliday EB, Brady C, Pipkin WC, Somerson JS . Equal Pay for Equal Work: Medicare Procedure Volume and Reimbursement for Male and Female Surgeons Performing Total Knee and Total Hip Arthroplasty. J Bone Joint Surg Am 100(4):e21, 2018. PMID: 29462043.
77. Holliday EB, Kuban DA, Levy LB, Bolukbasi Y, Master P, Choi S, Nguyen Q, McGuire SE, Mahmood U, Frank SJ, Hoffman KE . Select men benefit from androgen deprivation therapy delivered with salvage radiation therapy after prostatectomy. Prostate Cancer Prostatic Dis 20(4):389-394, 2017. e-Pub 2017. PMID: 28462945.
78. Holliday EB, Hunt A, You YN, Chang GJ, Skibber JM, Rodriguez-Bigas MA, Bednarski BK, Eng C, Koay EJ, Minsky BD, Taniguchi C, Krishnan S, Herman JM, Das P . Short course radiation as a component of definitive multidisciplinary treatment for select patients with metastatic rectal adenocarcinoma. J Gastrointest Oncol 8(6):990-997, 2017. PMID: 29299359.
79. Yoo SK, Ahmed AA, Ileto J, Zaorsky NG, Deville C, Holliday EB, Wilson LD, Jagsi R, Thomas CR . Industry Funding Among Leadership in Medical Oncology and Radiation Oncology in 2015. Int J Radiat Oncol Biol Phys 99(2):280-285, 2017. e-Pub 2017. PMID: 28366578.
80. Holliday EB, Bonner JA, Formenti SC, Hahn SM, Kalnicki S, Liu FF, Movsas B, Fuller CD, Thomas CR . Emotional Intelligence and Burnout in Academic Radiation Oncology Chairs. J Healthc Manag 62(5):302-313, 2017. PMID: 28885530.
81. Cope SR, Holliday EB, Somerson JS . Factors Associated With Publication Impact at Shoulder and Elbow Surgery Fellowships. J Surg Educ 74(5):883-888, 2017. e-Pub 2017. PMID: 28259487.
82. McClelland S, Thomas CR, Wilson LD, Holliday EB, Jaboin JJ . Association of preresidency peer-reviewed publications with radiation oncology resident choice of academic versus private practice career. Pract Radiat Oncol 7(5):364-367, 2017. e-Pub 2017. PMID: 28433523.
83. Holliday EB, Tao R, Brownlee Z, Das P, Krishnan S, Taniguchi C, Minsky BD, Herman JM, Kaseb A, Raghav K, Conrad C, Vauthey JN, Aloia TA, Chun YS, Crane CH, Koay EJ . Definitive radiation therapy for hepatocellular carcinoma with portal vein tumor thrombus. Clin Transl Radiat Oncol 4:39-45, 2017. e-Pub 2017. PMID: 29594206.
84. Ahmed AA, Hwang WT, Holliday EB, Chapman CH, Jagsi R, Thomas CR, Deville C . Female Representation in the Academic Oncology Physician Workforce: Radiation Oncology Losing Ground to Hematology Oncology. Int J Radiat Oncol Biol Phys 98(1):31-33, 2017. e-Pub 2017. PMID: 28587049.
85. Holliday EB, Kirsner SM, Thames HD, Mason BE, Nelson CL, Bloom ES . Lower mean heart dose with deep inspiration breath hold-whole breast irradiation compared with brachytherapy-based accelerated partial breast irradiation for women with left-sided tumors. Pract Radiat Oncol 7(2):80-85, 2017. e-Pub 2016. PMID: 28274398.
86. Farooqi AS, Holliday EB, Allen PK, Wei X, Cox JD, Komaki R . Prophylactic cranial irradiation after definitive chemoradiotherapy for limited-stage small cell lung cancer: Do all patients benefit?. Radiother Oncol 122(2):307-312, 2017. e-Pub 2017. PMID: 28073578.
87. Zhang C, Murata S, Murata M, Fuller CD, Thomas CR, Choi M, Holliday EB . Factors associated with increased academic productivity among US academic radiation oncology faculty. Pract Radiat Oncol 7(1):e59-e64, 2017. e-Pub 2016. PMID: 27637135.
88. Holliday EB, Swanick CW, McAvoy SA, Walker GV, Crane CH, Mahajan A, Das P . Development of a Comprehensive Clinical Radiation Oncology Resident Didactic Curriculum. J Am Coll Radiol 13(12 Pt A):1514-1516.e6, 2016. e-Pub 2016. PMID: 27554060.
89. Berriochoa C, Ward MC, Weller MA, Holliday EB, Kusano A, Thomas CR, Tendulkar RD . Applicant Interview Experiences and Postinterview Communication of the 2016 Radiation Oncology Match Cycle. Int J Radiat Oncol Biol Phys 96(3):514-20, 2016. e-Pub 2016. PMID: 27681747.
90. Holliday EB, Hampton DA, Thomas CR, Rana S . Prognostic value of the Yale Grading System for Superior Vena Cava Syndrome. Ann Am Thorac Soc 13(10):1862-1865, 2016. PMID: 27726436.
91. Diamond SJ, Thomas CR, Desai S, Holliday EB, Jagsi R, Schmitt C, Enestvedt BK . Gender Differences in Publication Productivity, Academic Rank, and Career Duration Among U.S. Academic Gastroenterology Faculty. Acad Med 91(8):1158-63, 2016. e-Pub 2016. PMID: 27144993.
92. McKeever MR, Sio TT, Gunn GB, Holliday EB, Blanchard P, Kies MS, Weber RS, Frank SJ . Reduced Acute Toxicity and Improved Efficacy from Intensity-Modulated Proton Therapy (IMPT) for the Management of head and Neck Cancer. Chin Clin Oncol 5(4):54, 2016. e-Pub 2016. PMID: 27506808.
93. Blanchard P, Garden AS, Gunn GB, Rosenthal DI, Morrison WH, Hernandez M, Crutison J, Lee JJ, Ye R, Fuller CD, Mohamed AS, Hutcheson KA, Holliday EB, Thaker NG, Sturgis EM, Kies MS, Zhu XR, Mohan R, Frank SJ . Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer – A case matched analysis. Radiother Oncol 120(1):48-55, 2016. e-Pub 2016. PMID: 27342249.
94. Ahmed AA, Holliday EB, Ileto J, Yoo SK, Green M, Orman A, Deville C, Jagsi R, Haffty BG, Wilson LD . Close to Home: Employment Outcomes for Recent Radiation Oncology Graduates. Int J Radiat Oncol Biol Phys 95(3):1017-21, 2016. e-Pub 2016. PMID: 27302515.
95. Ahmed AA, Holliday EB, Fakhreddine M, Yoo SK, Deville C, Jagsi R . Trends in Disclosures of Industry Sponsorship. Int J Radiat Oncol Biol Phys 95(4):1093-101, 2016. e-Pub 2016. PMID: 27130795.
96. Holliday EB, Esmaeli B, Pinckard J, Garden AS, Rosenthal DI, Morrison WH, Kies MS, Gunn GB, Fuller CD, Phan J, Beadle BM, Zhu XR, Zhang X, Frank SJ . A Multidisciplinary Orbit-Sparing Treatment Approach That Includes Proton Therapy for Epithelial Tumors of the Orbit and Ocular Adnexa. Int J Radiat Oncol Biol Phys 95(1):344-52, 2016. e-Pub 2015. PMID: 26454680.
97. Ence AK, Cope SR, Holliday EB, Somerson JS . Publication Productivity and Experience: Factors Associated with Academic Rank Among Orthopaedic Surgery Faculty in the United States. J Bone Joint Surg Am 98(10):e41, 2016. PMID: 27194503.
98. Fromme EK, Holliday EB, Nail LM, Lyons KS, Hribar MR, Thomas CR . Computerized patient-reported symptom assessment in radiotherapy: a pilot randomized, controlled trial. Support Care Cancer 24(4):1897-906, 2016. e-Pub 2015. PMID: 26471280.
99. Lewis GD, Holliday EB, Kocak-Uzel E, Hernandez M, Garden AS, Rosenthal DI, Frank SJ . Intensity-modulated proton therapy for nasopharyngeal carcinoma: Decreased radiation dose to normal structures and encouraging clinical outcomes. Head Neck 38 Suppl 1:E1886-95, 2016. e-Pub 2015. PMID: 26705956.
100. Ahmed AA, Holliday EB, Wilson LD . In Reply to Ye et al. Int J Radiat Oncol Biol Phys 94(5):1222-3, 2016. e-Pub 2016. PMID: 27026324.
101. Holliday EB, Frank SJ . Proton therapy for nasopharyngeal carcinoma. Chin Clin Oncol 5(2):25, 2016. PMID: 27121885.
102. Bhattasali O, Holliday E, Kies MS, Hanna EY, Garden AS, Rosenthal DI, Morrison WH, Gunn GB, Fuller CD, Zhu XR, Frank SJ . Definitive proton radiation therapy and concurrent cisplatin for unresectable head and neck adenoid cystic carcinoma: A series of 9 cases and a critical review of the literature. Head Neck 38 Suppl 1:E1472-80, 2016. e-Pub 2015. PMID: 26561041.
103. Holliday E, Fuller CD, Kalpathy-Cramer J, Gomez D, Rimner A, Li Y, Senan S, Wilson LD, Choi J, Komaki R, Thomas CR . Quantitative assessment of target delineation variability for thymic cancers; Agreement evaluation of a prospective segmentation challenge. J Radiat Oncol 5(1):55-61, 2016. e-Pub 2015. PMID: 27570583.
104. Holliday EB, Bhattasali O, Kies MS, Hanna E, Garden AS, Rosenthal DI, Morrison WH, Gunn GB, Phan J, Zhu XR, Frank SJ . Postoperative intensity-modulated proton therapy for head and neck Adenoid cystic carcinoma. Int J Particle Ther, 2016. e-Pub 2016. PMID: 31772965.
105. Holliday EB, Dieckmann NF, McDonald TL, Hung AY, Thomas CR, Wood LJ . Relationship between fatigue, sleep quality and inflammatory cytokines during external beam radiation therapy for prostate cancer: A prospective study. Radiother Oncol 118(1):105-11, 2016. e-Pub 2015. PMID: 26743832.
106. Holliday EB, Kocak-Uzel E, Feng L, Thaker NG, Blanchard P, Rosenthal DI, Gunn GB, Garden AS, Frank SJ . Dosimetric advantages of intensity-modulated proton therapy for oropharyngeal cancer compared with intensity-modulated radiation: A case-matched control analysis. Med Dosim 41(3):189-94, 2016. e-Pub 2016. PMID: 27158021.
107. Ahmed AA, Holliday EB, Deville C, Jagsi R, Haffty BG, Wilson LD . Attracting Future Radiation Oncologists: An Analysis of the National Resident Matching Program Data Trends From 2004 to 2015. Int J Radiat Oncol Biol Phys 93(5):965-7, 2015. e-Pub 2015. PMID: 26452568.
108. Holliday EB, Ahmed AA, Jagsi R, Stentz NC, Woodward WA, Fuller CD, Thomas CR . Pregnancy and Parenthood in Radiation Oncology, Views and Experiences Survey (PROVES): Results of a Blinded Prospective Trainee Parenting and Career Development Assessment. Int J Radiat Oncol Biol Phys 92(3):516-24, 2015. e-Pub 2015. PMID: 25892584.
109. Holliday EB, Thomas CR, Kusano AS . Integrity of the National Resident Matching Program for Radiation Oncology: National Survey of Applicant Experiences. Int J Radiat Oncol Biol Phys 92(3):525-31, 2015. e-Pub 2015. PMID: 25936811.
110. Holliday EB, Ahmed AA, Yoo SK, Jagsi R, Hoffman KE . Does Cancer Literature Reflect Multidisciplinary Practice? A Systematic Review of Oncology Studies in the Medical Literature Over a 20-Year Period. Int J Radiat Oncol Biol Phys 92(4):721-31, 2015. e-Pub 2015. PMID: 26104927.
111. Holliday EB, Mitra HS, Somerson JS, Rhines LD, Mahajan A, Brown PD, Grosshans DR . Postoperative proton therapy for chordomas and chondrosarcomas of the spine: adjuvant versus salvage radiation therapy. Spine (Phila Pa 1976) 40(8):544-9, 2015. PMID: 25627289.
112. Holliday E, Griffith KA, De Castro R, Stewart A, Ubel P, Jagsi R . Gender differences in resources and negotiation among highly motivated physician-scientists. J Gen Intern Med 30(4):401-7, 2015. e-Pub 2014. PMID: 25112462.
113. Awan M, Dyer BA, Kalpathy-Cramer J, Bongers E, Dahele M, Yang J, Walker GV, Thaker NG, Holliday EB, Bishop AJ, Thomas CR, Rosenthal DI, Fuller CD . Auto-segmentation of the brachial plexus assessed with TaCTICS – a software platform for rapid multiple-metric quantitative evaluation of contours. Acta Oncol 54(4):557-60, 2015. e-Pub 2014. PMID: 25279958.
114. Holliday EB, Yang G, Jagsi R, Hoffman KE, Bennett KE, Grace C, Zietman AL . Fate of manuscripts rejected from the Red Journal. Int J Radiat Oncol Biol Phys 91(1):3-10, 2015. PMID: 25835616.
115. Holliday EB, Garden AS, Rosenthal DI, Fuller CD, Morrison WH, Gunn GB, Phan J, Beadle BM, Zhu XR, Zhang X, Hanna E, Glisson BS, Hutcheson KA, El-Naggar AK, Hong JH, Hung TM, Kocak Uzel E, Lewis GL, Frank SJ . Proton therapy reduces treatment-related toxicities for patients with nasopharyngeal cancer: a case-match control study of intensity modulated proton therapy (IMPT) and intensity modulated photon therapy (IMRT). Int J Particle Therapy 2(1):19-28, 2015.
116. Holliday EB, Kusano A, Thomas CR Jr . Integrity of the national resident matching program for radiation oncology: national survey of applicant experiences. Int J Radiat Oncol Biol Phys 92(3):525-31, 2015.
117. Jagsi R, Bennett KE, Griffith KA, DeCastro R, Grace C, Holliday EB, Zietman AL . Attitudes toward blinding of peer review and perceptions of efficacy within a small biomedical specialty. Int J Radiat Oncol Biol Phys 89(5):940-946, 2014. e-Pub 2014. PMID: 25035195.
118. Holliday EB, Frank SJ . Proton radiation therapy for head and neck cancer: a review of the clinical experience to date. Int J Radiat Oncol Biol Phys 89(2):292-302, 2014. e-Pub 2014. PMID: 24837890.
119. Holliday EB, Jagsi R, Wilson LD, Choi M, Thomas CR, Fuller CD . Gender differences in publication productivity, academic position, career duration, and funding among U.S. academic radiation oncology faculty. Acad Med 89(5):767-73, 2014. PMID: 24667510.
120. Choi M, Holliday EB, Jagsi R, Wilson LD, Fuller CD, Thomas CR . Citation-based Estimation of Scholarly Activity Among Domestic Academic Radiation Oncologists: Five-Year Update. J Radiat Oncol 3(1):115-122, 2014. PMID: 24678385.
121. Holliday EB, Jagsi R, Thomas CR, Wilson LD, Fuller CD . Standing on the shoulders of giants: results from the Radiation Oncology Academic Development and Mentorship Assessment Project (ROADMAP). Int J Radiat Oncol Biol Phys 88(1):18-24, 2014. e-Pub 2013. PMID: 24210670.
122. Ahmed AA, Egleston B, Holliday E, Eastwick G, Takita C, Jagsi R . Gender trends in radiation oncology in the United States: a 30-year analysis. Int J Radiat Oncol Biol Phys 88(1):33-8, 2014. e-Pub 2013. PMID: 24189127.
123. Rana S, Holliday EB, Jagsi R, Wilson LD, Choi M, Thomas CR, Fuller CD . Scholastic activity among radiation oncology residents at US academic institutions: a benchmark analysis. J Cancer Educ 28(3):541-6, 2013. PMID: 23828146.
124. Awan M, Kalpathy-Cramer J, Gunn GB, Beadle BM, Garden AS, Phan J, Holliday EB, Jones WE, Maani E, Patel A, Choi J, Clyburn V, Tantiwongkosi B, Rosenthal DI, Fuller CD . Prospective assessment of an atlas-based intervention combined with real-time software feedback in contouring lymph node levels and organs-at-risk in the head and neck: quantitative assessment of conformance to expert delineation. Pract Radiat Oncol 3(3):186-193, 2013. e-Pub 2012. PMID: 24674363.
125. Holliday EB, Fuller CD, Wilson LD, Thomas CR . Success breeds success: authorship distribution in the Red Journal, 1975-2011. Int J Radiat Oncol Biol Phys 85(1):23-8, 2013. e-Pub 2012. PMID: 22560553.
126. Quigley MR, Holliday EB, Fuller CD, Choi M, Thomas CR . Distribution of the h-index in radiation oncology conforms to a variation of power law: implications for assessing academic productivity. J Cancer Educ 27(3):463-6, 2012. PMID: 22544537.
127. Holliday EB, Swanson GP, Du F, Basler JW . Older men with intermediate to high risk prostate cancer – patters of care and outcomes of treatment. Journal of Cancer Therapy 3:575-581, 2012.

Invited Articles

1. Holliday EB, Frank SJ. Current applications of proton beam radiation for the treatment of head and neck tumors. Otorinolaringo 64(1):1-11, 2014.
2. Holliday EB, Sulman EP. Tumor prognostic factors and the challenge of developing predictive factors. Curr Oncol Rep 15(1):33-46, 2013. PMID: 23224629.
3. Holliday EB, Jagsi R. Trends for female resident applications in radiation oncology. AAWR Focus Newsletter, 2013.